Showing Results for
- Academic Journals (199)
Search Results
- 199
Academic Journals
- 199
- Search Terms:
- 1From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Isaac E Hall1,2 , Edward P Stern3 , Lloyd G Cantley1 , Jack A Elias4 and Chirag R Parikh1,2 Background Acute kidney injury (AKI) is common and appears to be increasing among hospitalized patients [1-3]....
- 2From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Michael Bedford1 , Paul E Stevens1 , Toby WK Wheeler1 and Christopher KT Farmer1 Background Acute kidney injury (AKI) is a common clinical problem characterised by an abrupt decline in kidney function,...
- 3From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Yunlin Feng1 , Tao Jiang2 and Li Wang1 Background Acute tumor lysis syndrome (TLS) is a metabolic disorder manifesting as abrupt occurrence of acute kidney injury (AKI), metabolic acidosis and...
- 4From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Calvin J Meaney1,2 , Ziad Arabi3 , Rocco C Venuto3,5 , Joseph D Consiglio4 , Gregory E Wilding4 and Kathleen M Tornatore1,2,3 Background Renal transplantation is the preferred intervention for patients...
- 5From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Deidra C Crews1,2 , Orlando M Gutiñrrez3,4 , Stacey A Fedewa5 , Jean-Christophe Luthi5,6 , David Shoham7 , Suzanne E Judd8 , Neil R Powe9,10 and William M McClellan5,11 Background The risk of end-stage...
- 6From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Michelle C Mann1 , Derek V Exner1,2 , Brenda R Hemmelgarn1,3 , David A Hanley1,4 , Tanvir C Turin1 , Jennifer M MacRae1 and Sofia B Ahmed1 Background More than 40,000 Canadians live with end-stage...
- 7From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Heng-Jung Hsu1,2,3 , Chiung-Hui Yen4 , Kuang-Hung Hsu5 , I-Wen Wu1,3 , Chin-Chan Lee1,3 , Ming-Jui Hung2,3,6 , Chiao-Yin Sun1,3 , Chia-Chi Chou1,3 , Yung-Chih Chen1,3 , Ming-Fang Hsieh1,3 , Chun-Yu Chen1,3 ,...
- 8From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Miyeun Han1 , Hayne Cho Park1,2 , Hyunsuk Kim1 , Hyung Ah Jo1 , Hyuk Huh1 , Joon Young Jang3 , Ah-Young Kang3,4 , Seung Hyup Kim5,6 , Hae Il Cheong2,6,7 , Duk-Hee Kang8 , Jaeseok Yang3,9 , Kook-Hwan Oh1 ,...
- 9From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedBackground Activated vitamin D is the mainstay of treatment for secondary hyperparathyroidism (SHPT) in chronic hemodialysis patients. However, the optimal route of administration is still debated. The aim of our...
- 10From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedContributing reviewers The editors of BMC Nephrology would like to thank all our reviewers who have contributed to the journal in Volume 13 (2013). Author(s): Hayley Henderson1 Ali Inal Turkey Hanna...
- 11From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedBackground Expression and/or excretion of fibroblast growth factor-23 (FGF23) and its co-receptor Klotho are altered in patients with end-stage renal disease. The possibility that the FGF23/[alpha]-Klotho system...
- 12From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedBackground No consensus exists on how to define abnormally rapid deterioration in renal function (Rapid Progression, RP). We developed an operational definition of RP in HIV-positive persons with baseline estimated...
- 13From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedBackground Chronic kidney disease (CKD) is a progressive and usually irreversible disease. Different types of outcomes are of interest in the course of CKD such as time-to-dialysis, transplantation or decline of the...
- 14From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedBackground Experimental models are important to the understanding of the pathophysiology of, as well as the effects of therapy on, certain diseases. In the case of chronic kidney disease-mineral bone disorder, there...
- 15From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Lee-Moay Lim1,2 , Hung-Tien Kuo1,3 , Mei-Chuan Kuo1 , Yi-Wen Chiu1,3 , Jia-Jung Lee1 , Shang-Jyh Hwang1,3 , Jer-Chia Tsai1,3 , Chi-Chih Hung1 and Hung-Chun Chen1,3 Background Bone mineral disorders have...
- 16From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Steven M Brunelli1 , Steven Wilson2 , Mahesh Krishnan2 and Allen R Nissenson2,3 Background Since the founding of National Medical Corporation, the first for-profit dialysis chain, in the early 1970's...
- 17From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Seiji Nagamachi1 , Isao Ohsawa1 , Hiyori Suzuki1 , Nobuyuki Sato1 , Hiroyuki Inoshita1 , Atsuko Hisada1 , Daisuke Honda1 , Mamiko Shimamoto1 , Yoshio Shimizu1 , Satoshi Horikoshi1 and Yasuhiko Tomino1...
- 18From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Adrian P Abreo1 , David Glidden2 , Patricia Painter3 , Janice Lea4 , Charles A Herzog5,6 , Nancy G Kutner7 and Kirsten L Johansen2,7,8,9,10,11 Background Recent studies have suggested the need for...
- 19From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Andrew P McGovern1 , Simon Jones1 , Jeremy van Vlymen1 , Anand K Saggar2 , Richard Sandford3 and Simon de Lusignan1 Background Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of...
- 20From: BMC Nephrology. (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Jun Zhang1 , Cheng Wang1 , Wenyu Gong1 , Hui Peng1 , Ying Tang2 , Cui Cui Li1 , Wenbo Zhao1 , Zengchun Ye1 and Tanqi Lou1 Background Sleep-related problems and disorders are common problems in end-stage...